Online citations, reference lists, and bibliographies.
← Back to Search

Priming With Chlamydia Trachomatis Major Outer Membrane Protein (MOMP) DNA Followed By MOMP ISCOM Boosting Enhances Protection And Is Associated With Increased Immunoglobulin A And Th1 Cellular Immune Responses

Zhang Dong-ji, Xi Yang, Caixia Shen, Hong Lu, A. Murdin, R. Brunham
Published 2000 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
ABSTRACT We previously reported that DNA vaccination was able to elicit cellular immune responses and partial protection againstChlamydia trachomatis infection. However, DNA immunization alone did not generate immune responses or protection as great as that induced by using live organisms. In this study, we evaluated the immunologic effects of a combinational vaccination approach usingC. trachomatis mouse pneumonitis (MoPn) major outer membrane protein (MOMP) DNA priming followed by boosting with immune-stimulating complexes (ISCOM) of MOMP protein (MOMP ISCOM) for protection of BALB/c mice against MoPn lung infection. Substantially better protection to challenge infection was observed in mice given combinational vaccination compared with mice given MOMP ISCOM immunization alone, and the protection approximated that induced by live organisms. Enhanced protection was correlated with stronger delayed-type hypersensitivity, higher levels of gamma interferon production, and increased immunoglobulin A antibody responses in lung homogenates. The results indicate that DNA priming followed by ISCOM protein boosting may be useful in designing a fully protective chlamydial vaccine.
This paper references
Chlamydial infections. Pt. 3.
J. Schachter (1978)
10.1056/NEJM197803092981005
Chlamydial infections (third of three parts).
J. Schachter (1978)
10.1128/IAI.53.2.347-351.1986
Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells
G. Byrne (1986)
10.1128/iai.57.1.152-157.1989
Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections
G. Zhong (1989)
10.1093/INFDIS/163.4.752
Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area.
S. West (1991)
10.1097/00002030-199301000-00015
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.
M. Laga (1993)
Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis.
M. Starnbach (1994)
10.1128/IAI.62.11.5195-5197.1994
Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones
J. Igietseme (1994)
Chlamydia trachomatis antigens: role in immunity and pathogenesis.
R. Brunham (1994)
Role for CD81 T cells in antichlamydial immunity defined by chlamydia-specific T lymphocyte clones
J.U.D. Igietseme (1994)
10.1084/JEM.181.4.1493
Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis
J. Ho (1995)
10.1084/JEM.182.5.1493
The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire
M. Scherer (1995)
10.1128/iai.63.12.4661-4668.1995
Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection
R. Morrison (1995)
10.1128/iai.63.9.3302-3308.1995
CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract
H. Su (1995)
Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.
X. Yang (1996)
The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide.
J. Igietseme (1996)
10.1016/0020-2452(96)85300-0
Prospects for a vaccine against Chlamydia genital disease II. — Immunity and vaccine development
R. Rank (1996)
10.1046/j.1365-2567.1996.d01-655.x
Molecular mechanism of T‐cell control of Chlamydia in mice: role of nitric oxide in vivo
J. Igietseme (1996)
10.1128/iai.65.3.1032-1044.1997
Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response
M. Johansson (1997)
10.1073/PNAS.94.17.9378
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.
N. Letvin (1997)
10.1086/516545
DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection.
D. Zhang (1997)
10.1155/1998/395297
T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.
X. Yang (1998)
Iscom, a delivery system for parenteral and mucosal vaccination.
B. Morein (1998)
10.1128/IAI.66.11.5494-5500.1998
High-Level Expression of Chlamydia psittaci Major Outer Membrane Protein in COS Cells and in Skeletal Muscles of Turkeys
D. Vanrompay (1998)
10.1046/j.1365-3083.1999.00543.x
Characterization of Antibody Responses to a Plasmodium falciparum Blood‐Stage Antigen Induced by a DNA Prime/Protein Boost Immunization Protocol
Haddad (1999)
10.1016/S0264-410X(99)00053-5
Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations.
D. Vanrompay (1999)
10.1128/.67.4.1606-1613.1999
Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocyte-macrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation.
D. Zhang (1999)
10.1046/j.1365-2567.1999.00682.x
Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain
Zhang (1999)
10.1128/IAI.67.4.1606-1613.1999
Immunity to Chlamydia trachomatis Mouse Pneumonitis Induced by Vaccination with Live Organisms Correlates with Early Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-12 Production and with Dendritic Cell-Like Maturation
Dongji Zhang (1999)
Characterization of antibody response to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization
D. Haddad (1999)
10.1086/315605
Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
A. Murdin (2000)
Use of a mouse lung model to identify antigens protective against Chlamydia pneumoniae lung infection
A. D. Murdin (2000)
10.3109/9781420020977-11
Chlamydial infections.
D. Coonrod (2002)



This paper is referenced by
Plant Archives
Mayuri. P. Pol (2021)
10.1016/j.vaccine.2021.03.043
Chlamydia trachomatis: Cell biology, immunology and vaccination.
Sam M Murray (2021)
10.1016/j.vaccine.2020.04.065
Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant.
D. Tifrea (2020)
10.1080/1040841X.2020.1730300
Chlamydia: what is on the outside does matter
Arlieke Gitsels (2020)
10.1371/journal.pone.0210245
Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus)
Sharon Nyari (2019)
10.1111/imcb.12285
Chlamydia‐infected macrophages are resistant to azithromycin treatment and are associated with chronic oviduct inflammation and hydrosalpinx development
M. Harvie (2019)
10.29350/jops.2018.23.2.739
Estimated levels of some Hormones and immunoglobulin G,M in women infected with Chlamydia trachomatis in Al-Najaf governorate, Iraq.
Maysoon k.A. Al-Hadrawi (2018)
10.1007/978-3-319-71232-1
Biology of Chlamydia
G. Häcker (2018)
10.1007/82_2016_6
Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
Taylor B Poston (2018)
10.1128/CVI.00543-16
Update on Chlamydia trachomatis Vaccinology
L. M. de la Maza (2017)
10.1016/j.vaccine.2017.02.020
The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
S. Pal (2017)
10.1016/j.vaccine.2017.04.031
Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.
Pengfei Jiang (2017)
10.3389/fimmu.2016.00162
A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance
Alexander Badamchi-Zadeh (2016)
10.1111/imm.12520
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge
S. Pal (2015)
Immunisation with recombinant polymorphic membrane protein D elicits robust protection against sexually transmitted Chlamydia trachomatis infection
William Neville Wayne Paes (2015)
10.1007/978-3-319-11280-0_6
Immuno-modulatory role of porins: host immune responses, signaling mechanisms and vaccine potential.
Sanica C. Sakharwade (2015)
10.18632/oncotarget.6533
Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection
Pengfei Jiang (2015)
10.5772/57542
Immune Regulation of Chlamydia trachomatis Infections of the Female Genital Tract
L. Hafner (2014)
10.4049/jimmunol.1303392
Increased Immunoaccessibility of MOMP Epitopes in a Vaccine Formulated with Amphipols May Account for the Very Robust Protection Elicited against a Vaginal Challenge with Chlamydia muridarum
D. Tifrea (2014)
10.4161/hv.29683
Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis
J. Rey-Ladino (2014)
10.1128/CMR.00105-13
Genital Chlamydia trachomatis: Understanding the Roles of Innate and Adaptive Immunity in Vaccine Research
S. Vasilevsky (2014)
10.1016/j.vaccine.2013.08.020
Development status and future prospects for a vaccine against Chlamydia trachomatis infection.
Louise M. Hafner (2014)
Chlamydiozy dróg moczowo-płciowych u ludzi Chlamydiosis of urogenitary tract in humans
Wydział Biologii (2014)
10.1007/978-3-642-36853-0_4
Nanotechnological Approaches for Genetic Immunization
A. Goyal (2013)
10.1016/j.micinf.2013.02.001
Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.
Chunxue Lu (2013)
10.1016/B978-0-12-391059-2.00015-2
Chapter 15 – Chlamydia
L. Hafner (2013)
10.1016/j.intimp.2013.04.027
Evaluation of an ompA-based phage-mediated DNA vaccine against Chlamydia abortus in piglets.
Changbo Ou (2013)
10.1007/978-3-642-36853-0
DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
V. Erdmann (2013)
10.1586/eci.11.80
Vaccination to protect against infection of the female reproductive tract
W. Huston (2012)
10.2165/00063030-200216010-00003
Chlamydia Vaccines
J. Igietseme (2012)
10.1016/j.vaccine.2010.12.132
Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1.
W. Xu (2011)
10.1016/j.vetimm.2011.08.003
Protection of mice against Chlamydophila abortus infection with a bacteriophage-mediated DNA vaccine expressing the major outer membrane protein.
Y. Ling (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar